GlassScriptPhysician profile
James N Dreyfus
NPI 1083673552
$2,731.39
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,241 · 2020: $441 · 2021: $24.19 · 2022: $25.01.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $377.42 | 2019-2020 | |
| Genzyme Corporation | $323.38 | 2019-2020 | |
| Abbvie INC. | $248.13 | 2019-2020 | |
| Amgen INC. | $243.41 | 2019-2020 | |
| Janssen Biotech, INC. | $240.98 | 2019-2020 | |
| Genentech USA, INC. | $209.48 | 2019-2020 | |
| Ucb, INC. | $184.60 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $134.23 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $123.16 | 2019-2022 | |
| Glaxosmithkline, LLC. | $118.32 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $90.99 | 2019 | |
| Abbott Laboratories | $78.67 | 2019 | |
| Pfizer INC. | $60.33 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $45.04 | 2019 | |
| Radius Health, INC. | $38.13 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $37.79 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $36.51 | 2019 | |
| Lilly USA, LLC | $33.00 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.83 | 2019 | |
| Sobi, INC | $26.19 | 2019 | |
| Merck Sharp & Dohme LLC | $14.40 | 2019 | |
| Shire North American Group INC | $14.36 | 2019 | |
| Medexus Pharma, INC. | $11.93 | 2019 | |
| Ferring Pharmaceuticals INC. | $11.11 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Dreyfus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.